135 related articles for article (PubMed ID: 11716993)
1. Mammographic density increase in women receiving different hormone replacement regimens.
Erel CT; Esen G; Seyisoglu H; Elter K; Uras C; Ertungealp E; Aksu MF
Maturitas; 2001 Nov; 40(2):151-7. PubMed ID: 11716993
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
[TBL] [Abstract][Full Text] [Related]
4. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
6. Effects of different types of hormone replacement therapy on mammographic density.
Colacurci N; Fornaro F; De Franciscis P; Palermo M; del Vecchio W
Maturitas; 2001 Nov; 40(2):159-64. PubMed ID: 11716994
[TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density changes during different postmenopausal hormone replacement therapies.
Sendağ F; Coşan Terek M; Ozşener S; Oztekin K; Bilgin O; Bilgen I; Memiş A
Fertil Steril; 2001 Sep; 76(3):445-50. PubMed ID: 11532462
[TBL] [Abstract][Full Text] [Related]
10. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
[TBL] [Abstract][Full Text] [Related]
11. The effect of various regimens of hormone replacement therapy on mammographic breast density.
Christodoulakos GE; Lambrinoudaki IV; Panoulis KP; Vourtsi AD; Vlachos L; Georgiou E; Creatsas GC
Maturitas; 2003 Jun; 45(2):109-18. PubMed ID: 12787969
[TBL] [Abstract][Full Text] [Related]
12. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
13. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
15. The effect of low dose hormone therapy on mammographic breast density.
Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Vlachou S; Creatsa M; Panoulis KP; Botsis D
Maturitas; 2006 Apr; 54(1):78-85. PubMed ID: 16198519
[TBL] [Abstract][Full Text] [Related]
16. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
17. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
Odmark IS; Carlström K; Jonsson B; Jonasson AF
Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
[TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
19. Mammographic breast density changes after 1 year of tibolone use.
Kutlu T; Fiçicioğlu C; Başaran T; Başaran E; Topaloğlu T
Maturitas; 2004 Jun; 48(2):133-6. PubMed ID: 15172087
[TBL] [Abstract][Full Text] [Related]
20. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
